Supply Chain news and information

ICU Medical, the San Clemente, Calif.-based producer of intravenous medical equipment, is weighing a sale that may fetch more than $1 billion, said people familiar with the matter. The shares rose to their highest closing price since first being sold to the public 21 years ago.
FULL STORY »

HHS keeps a list of people who are excluded from giving even indirect care to Medicare patients, and new guidelines urge providers to check their personnel rosters against the list once a month.
FULL STORY »

It's likely to be another seven weeks before the Food and Drug Administration finalizes long-awaited regulations that will require manufacturers to mark medical devices with unique identifiers that are expected to help track products during recalls, save money and improve patient safety.
FULL STORY »

Modern Healthcare's second annual Survey of Executive Opinions on Supply Chain Issues is now open for participation. This survey is intended for senior healthcare executives in an effort to analyze their opinion on supply chain issues that effect their business decisions and relationships with...
FULL STORY »

The government is moving the morning-after pill over the counter but only those 15 and older can buy it.
FULL STORY »

The head of Europe's medicines regulator is digging in for a fight over data transparency after being stopped from releasing information on drugs from two U.S. companies by a court ruling.
FULL STORY »

A study of conflicts of interest in leading cancer journals showed financial connections between authors and companies sponsoring phase 3 clinical trials had little impact on interpretation of the results.
FULL STORY »

German drug company Bayer says it has agreed to buy California-based Conceptus for around $1.1 billion to expand the kinds of birth control it offers.
FULL STORY »

Canada's largest listed drug maker, Valeant Pharmaceuticals International Inc, is in talks to buy generic drugmaker Actavis Inc for more than $13 billion, a person familiar with the situation told Reuters on Friday night.
FULL STORY »

In an effort to find a treatment for autism, scientists at the University of California, Los Angeles, are leading a $9 million experiment that aims to evaluate the effectiveness of drugs within weeks rather than years.
FULL STORY »